Carle Health Partners with Health Catalyst to Achieve Data-Informed Improvement
Health Catalyst, a leading provider of data and analytics technology and services to healthcare organizations, today announced an expansive, multi-year contract with Carle Health (Carle)—an integrated health system based in Urbana, Illinois that includes five hospitals, multi-specialty physician group practices with more than 1,000 doctors and advanced practice providers, and Health Alliance Medical Plans—deepening its relationship with Health Catalyst to further advance Carle’s innovative analytics capabilities system-wide.
“Carle Health is excited to announce this novel partnership with Health Catalyst. When combined with our own clinical expertise, Health Catalyst will help us transform the way we use data to support organizational decisions and improve patient outcomes,” said Carle Chief Operating Officer, Matthew Kolb. “As a transformative health care system, it’s important that we lay the groundwork to ensure we’re able to provide the right solutions that blend data, analytics, and medical expertise to optimize the quality of care we provide for everyone who depend on us.”
Strengthening the existing relationship between Health Catalyst and Carle, this five-year agreement will include an all-access technology subscription, plus tech-enabled managed services in the areas of analytics, data management, reporting, and project management.
Beginning in January 2023, Carle Health Clinical and Business Intelligence (CBI) team members will transfer employment to Health Catalyst, where they will have the opportunity to grow professionally within Health Catalyst’s enhanced environment of data literacy and technology resources. As Health Catalyst employees, transitioned team members will constitute a specialized, expert team that will continue to provide analytics support and innovation to the Carle Health system.
“We’re grateful to have been a partner with such a high-performing health system as Carle these past two years, contributing to its data-driven healthcare transformation efforts,” said Dan Burton, CEO of Health Catalyst. “We are honored to have been chosen by Carle to continue supporting them in bringing more technology to complement and strengthen their healthcare services. Carle Health will realize greater data-informed opportunities through this partnership and we look forward to the improvements they will continue to make for their patients and the larger community.”
Health Catalyst is focused on deepening and strengthening existing partnerships to help clients achieve massive, measurable healthcare improvement. Health Catalyst and Carle first entered a partnership in 2020, which enabled Carle to leverage an open, scalable data platform to gain access to data and analytics solutions to measure quality and cost of care, allowing for increased and efficient sharing of analytics, and provide a comparative analytics platform to help increase learnings about costs, outcomes, and trending best practices.
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more